标题
Host Immunity and Immunization Strategies for Clostridioides difficile Infection
作者
关键词
-
出版物
CLINICAL MICROBIOLOGY REVIEWS
Volume 36, Issue 2, Pages -
出版商
American Society for Microbiology
发表日期
2023-05-10
DOI
10.1128/cmr.00157-22
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Detection of Newly Secreted Antibodies Predicts Non-recurrence in Primary Clostridioides difficile Infection
- (2022) Natalie S. Haddad et al. JOURNAL OF CLINICAL MICROBIOLOGY
- SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
- (2022) Paul Feuerstadt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Binary Toxin Expression by Clostridioides difficile Is Associated With Worse Disease
- (2022) Mary K Young et al. Open Forum Infectious Diseases
- TFPI is a colonic crypt receptor for TcdB from hypervirulent clade 2 C. difficile
- (2022) Jianhua Luo et al. CELL
- Towards Development of a Non-Toxigenic Clostridioides difficile Oral Spore Vaccine against Toxigenic C. difficile
- (2022) Jaime Hughes et al. Pharmaceutics
- Development of an Effective Nontoxigenic Clostridioides difficile–Based Oral Vaccine against C. difficile Infection
- (2022) Shaohui Wang et al. Microbiology Spectrum
- Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota
- (2021) Joshua R. Fletcher et al. Nature Communications
- Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection
- (2021) Eric R. Littmann et al. Nature Communications
- Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology
- (2021) Zhenrui Pan et al. PLoS Pathogens
- C. difficile exploits a host metabolite produced during toxin-mediated disease
- (2021) Kali M. Pruss et al. NATURE
- Large Clostridial Toxins: Mechanisms and Roles in Disease
- (2021) Kathleen E. Orrell et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota
- (2020) Hiroko Nagao-Kitamoto et al. NATURE MEDICINE
- Considering the Immune System during Fecal Microbiota Transplantation for Clostridioides difficile Infection
- (2020) Alyse L. Frisbee et al. TRENDS IN MOLECULAR MEDICINE
- Clostridium difficile Infection: An Epidemiology Update
- (2020) Ana C. De Roo et al. Clinics in Colon and Rectal Surgery
- The Inflammasome and Type-2 Immunity in Clostridium difficile Infection
- (2020) Alexandra Donlan et al. Clinics in Colon and Rectal Surgery
- Diarrhoeal events can trigger long-term Clostridium difficile colonization with recurrent blooms
- (2020) David VanInsberghe et al. Nature Microbiology
- Enabling anti-tumor immunity by unleashing ILC2
- (2020) Irene Mattiola et al. CELL RESEARCH
- Interaction between microbiota and immunity in health and disease
- (2020) Danping Zheng et al. CELL RESEARCH
- SER-109, an Investigational Microbiome Drug to Reduce Recurrence after Clostridioides difficile infection: Lessons Learned from a Phase 2 Trial
- (2020) Barbara H McGovern et al. CLINICAL INFECTIOUS DISEASES
- IL-17–producing γδ T cells protect against Clostridium difficile infection
- (2020) Yee-Shiuan Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes
- (2020) Alice Y. Guh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Plasminogen Exacerbates Clostridioides difficile Enteric Disease and Alters the Spore Surface
- (2020) M.M. Awad et al. GASTROENTEROLOGY
- Human C. difficile toxin-specific memory B cell repertoires encode poorly-neutralizing antibodies
- (2020) Hemangi B. Shah et al. JCI Insight
- Subtyping analysis reveals new variants and accelerated evolution of Clostridioides difficile toxin B
- (2020) Enhui Shen et al. Communications Biology
- Gold Nanoclusters as an Antibacterial Alternative Against Clostridium difficile
- (2020) Huan Yang et al. International Journal of Nanomedicine
- The adaptive immune response to Clostridioides difficile : A tricky balance between immunoprotection and immunopathogenesis
- (2020) Rodrigo Emanuel Hernández Del Pino et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial
- (2020) Guy de Bruyn et al. LANCET INFECTIOUS DISEASES
- Reuterin disrupts Clostridioides difficile metabolism and pathogenicity through reactive oxygen species generation
- (2020) Melinda A. Engevik et al. Gut Microbes
- Type 2 cytokines IL-4 and IL-5 reduce severe outcomes from Clostridiodes difficile infection
- (2020) Alexandra N. Donlan et al. ANAEROBE
- Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B
- (2020) Laura Cook et al. GASTROENTEROLOGY
- Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection — An observational cohort study
- (2020) Sylvia Polivkova et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- New insights for vaccine development against Clostridium difficile infections
- (2019) Marjorie Pizarro-Guajardo et al. ANAEROBE
- Colitis-Induced Th17 Cells Increase the Risk for Severe Subsequent Clostridium difficile Infection
- (2019) Mahmoud M. Saleh et al. Cell Host & Microbe
- IL-33 drives group 2 innate lymphoid cell-mediated protection during Clostridium difficile infection
- (2019) Alyse L. Frisbee et al. Nature Communications
- Innate Lymphoid Cells in the Induction of Obesity
- (2019) Takaharu Sasaki et al. Cell Reports
- “The recent emergence of a highly related virulent Clostridium difficile clade with unique characteristics”
- (2019) Helen Alexandra Shaw et al. CLINICAL MICROBIOLOGY AND INFECTION
- The interaction of intestinal microbiota and innate lymphoid cells in health and disease throughout life
- (2019) Stephanie C. Ganal‐Vonarburg et al. IMMUNOLOGY
- Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
- (2019) Zachariah DeFilipp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity and Protection from Receptor-Binding Domains of Toxins as Potential Vaccine Candidates for Clostridium difficile
- (2019) Deyan Luo et al. Vaccines
- Characterization of the Immune Response during Infection Caused by Clostridioides difficile
- (2019) Hamo et al. Microorganisms
- Clostridioides difficile Infection Induces an Inferior IgG Response to That Induced by Immunization and Is Associated with a Lack of T Follicular Helper Cell and Memory B Cell Expansion
- (2019) Souwelimatou Amadou Amani et al. INFECTION AND IMMUNITY
- Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2
- (2019) José Luís Fachi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Therapeutic Mechanism of Macrophage Inflammatory Protein 1 α Neutralizing Antibody (CCL3) in Clostridium difficile Infection in Mice
- (2019) Jiani Wang et al. JOURNAL OF INFECTIOUS DISEASES
- Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
- (2018) L Clifford McDonald et al. CLINICAL INFECTIOUS DISEASES
- Understanding Clostridium difficile Colonization
- (2018) Monique J. T. Crobach et al. CLINICAL MICROBIOLOGY REVIEWS
- Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota
- (2018) Julie A.K. McDonald et al. GASTROENTEROLOGY
- The ATP-P2X7 Signaling Axis Is an Essential Sentinel for Intracellular Clostridium difficile Pathogen-Induced Inflammasome Activation
- (2018) Ya-Hui Liu et al. Frontiers in Cellular and Infection Microbiology
- Clostridioides difficile Biology: Sporulation, Germination, and Corresponding Therapies for C. difficile Infection
- (2018) Duolong Zhu et al. Frontiers in Cellular and Infection Microbiology
- Nuts and Bolts of Fecal Microbiota Transplantation
- (2018) Edward Krajicek et al. Clinical Gastroenterology and Hepatology
- Safety and efficacy of a minimally invasive cell sampling device (‘Cytosponge’) in the diagnosis of esophageal pathology
- (2018) Umair Iqbal et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The use of faecal microbiota transplant as treatment for recurrent or refractoryClostridium difficileinfection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
- (2018) Benjamin H Mullish et al. GUT
- Oral immunization with non-toxic C. difficile strains expressing chimeric fragments of TcdA and TcdB elicits protective immunity against C. difficile infection in both mice and hamsters
- (2018) Yuanguo Wang et al. INFECTION AND IMMUNITY
- Diagnosis and Treatment of Clostridium difficile Infection
- (2018) Arjun Gupta et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Development and Validation of a Prediction Model for Mortality and Adverse Outcomes Among Patients With Peripheral Eosinopenia on Admission for Clostridium difficile Infection
- (2018) Audrey S. Kulaylat et al. JAMA Surgery
- A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients
- (2018) Oluwaseun Shogbesan et al. Canadian Journal of Gastroenterology and Hepatology
- Five years of fecal microbiota transplantation - an update of the Israeli experience
- (2018) Sharon A Greenberg et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis
- (2018) Pedro H. V. Saavedra et al. Nature Communications
- Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
- (2017) Mark H. Wilcox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains
- (2017) Susan Secore et al. PLoS One
- Immunization with Recombinant TcdB-Encapsulated Nanocomplex Induces Protection against Clostridium difficile Challenge in a Mouse Model
- (2017) Yi-Wen Liu et al. Frontiers in Microbiology
- Induction of antitoxin responses in Clostridium-difficile-infected patients compared to healthy blood donors
- (2016) Alice von Eichel-Streiber et al. ANAEROBE
- Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections
- (2016) Shinsmon Jose et al. ANAEROBE
- Immunogenic properties of the surface layer precursor of Clostridium difficile and vaccination assays in animal models
- (2016) J.-F. Bruxelle et al. ANAEROBE
- Interaction of gut microbiota with bile acid metabolism and its influence on disease states
- (2016) Christopher Staley et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile
- (2016) Bao-Zhong Zhang et al. BMC INFECTIOUS DISEASES
- Antibodies to Toxin B Are Protective AgainstClostridium difficileInfection Recurrence
- (2016) Swati B. Gupta et al. CLINICAL INFECTIOUS DISEASES
- Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa
- (2016) B. Kullin et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Analysis of TcdB Proteins within the Hypervirulent Clade 2 Reveals an Impact of RhoA Glucosylation on Clostridium difficile Proinflammatory Activities
- (2016) Carlos Quesada-Gómez et al. INFECTION AND IMMUNITY
- Coordination between T helper cells, iNKT cells, and their follicular helper subsets in the humoral immune response against Clostridium difficile toxin B
- (2016) Pragya Rampuria et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers
- (2016) Nicole Bézay et al. VACCINE
- Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial
- (2016) Guy de Bruyn et al. VACCINE
- Microbiota-Regulated IL-25 Increases Eosinophil Number to Provide Protection during Clostridium difficile Infection
- (2016) Erica L. Buonomo et al. Cell Reports
- Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects
- (2016) Stefano Di Bella et al. Toxins
- Immunogenicity and protective efficacy of recombinant Clostridium difficile flagellar protein FliC
- (2016) Chandrabali Ghose et al. Emerging Microbes & Infections
- Clostridium difficile infection
- (2016) Wiep Klaas Smits et al. Nature Reviews Disease Primers
- The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia
- (2016) Carrie A. Cowardin et al. Nature Microbiology
- Multi-functional nano silver: A novel disruptive and theranostic agent for pathogenic organisms in real-time
- (2016) Ponnusamy Manogaran Gopinath et al. Scientific Reports
- Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection
- (2015) Michael C. Abt et al. Cell Host & Microbe
- Fatal Aspiration Pneumonia as a Complication of Fecal Microbiota Transplant
- (2015) M. Baxter et al. CLINICAL INFECTIOUS DISEASES
- Diversity and Evolution in the Genome of Clostridium difficile
- (2015) Daniel R. Knight et al. CLINICAL MICROBIOLOGY REVIEWS
- Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B
- (2015) T. Scott Devera et al. INFECTION AND IMMUNITY
- Outcomes of Clostridium difficile Infection in Hospitalized Leukemia Patients: A Nationwide Analysis
- (2015) Ruihong Luo et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- The Prospect for Vaccines to Prevent Clostridium difficile Infection
- (2015) Chandrabali Ghose et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Administration of Spores of NontoxigenicClostridium difficileStrain M3 for Prevention of RecurrentC difficileInfection
- (2015) Dale N. Gerding et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Exposure of Neutralizing Epitopes in the Carboxyl-terminal Domain of TcdB Is Altered by a Proximal Hypervariable Region
- (2015) Jason L. Larabee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genomic Epidemiology of a Protracted Hospital Outbreak Caused by a Toxin A-Negative Clostridium difficile Sublineage PCR Ribotype 017 Strain in London, England
- (2015) M. D. Cairns et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Clostridium difficile Infection
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Burden of Clostridium difficile Infection in the United States
- (2015) Fernanda C. Lessa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammasome Activation Contributes to Interleukin-23 Production in Response to Clostridium difficile
- (2015) Carrie A. Cowardin et al. mBio
- Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections
- (2015) Glen P. Carter et al. mBio
- Clostridium difficile: New Insights into the Evolution of the Pathogenicity Locus
- (2015) Marc Monot et al. Scientific Reports
- Tempered Enthusiasm for Fecal Transplant
- (2014) P. R. Solari et al. CLINICAL INFECTIOUS DISEASES
- Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials
- (2014) Stuart Johnson et al. CLINICAL INFECTIOUS DISEASES
- Humoral immune response as predictor of recurrence in Clostridium difficile infection
- (2014) M.P. Bauer et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immunomodulatory properties of the vaccine adjuvant alum
- (2014) Ewa Oleszycka et al. CURRENT OPINION IN IMMUNOLOGY
- Plasma cell numbers decrease in bone marrow of old patients
- (2014) Theresa Pritz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- MHC-II: A Mutual Support System for ILCs and T Cells?
- (2014) Rick M. Maizels et al. IMMUNITY
- Group 2 Innate Lymphoid Cells Are Critical for the Initiation of Adaptive T Helper 2 Cell-Mediated Allergic Lung Inflammation
- (2014) Timotheus Y.F. Halim et al. IMMUNITY
- MHCII-Mediated Dialog between Group 2 Innate Lymphoid Cells and CD4+ T Cells Potentiates Type 2 Immunity and Promotes Parasitic Helminth Expulsion
- (2014) Christopher J. Oliphant et al. IMMUNITY
- Interleukin-22 Regulates the Complement System to Promote Resistance against Pathobionts after Pathogen-Induced Intestinal Damage
- (2014) Mizuho Hasegawa et al. IMMUNITY
- Oral, Capsulized, Frozen Fecal Microbiota Transplantation for RelapsingClostridium difficileInfection
- (2014) Ilan Youngster et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens
- (2014) Theresa L. Geiger et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Clostridium difficile recurrence is characterized by pro-inflammatory peripheral blood mononuclear cell (PBMC) phenotype
- (2014) M. B. Yacyshyn et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Synthetic Polymers Active against Clostridium difficile Vegetative Cell Growth and Spore Outgrowth
- (2014) Runhui Liu et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome
- (2014) Hao Xu et al. NATURE
- Activated group 3 innate lymphoid cells promote T-cell-mediated immune responses
- (2014) N. von Burg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Risk factors for recurrentClostridium difficileinfection in hematopoietic stem cell transplant recipients
- (2014) A.M. Huang et al. Transplant Infectious Disease
- Vaccines against Clostridium difficile
- (2014) Rosanna Leuzzi et al. Human Vaccines & Immunotherapeutics
- Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis
- (2013) Zain Kassam et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection
- (2013) Kevin A. Brown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Transient Flare of Ulcerative Colitis After Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
- (2013) Lauren M. De Leon et al. Clinical Gastroenterology and Hepatology
- Editorial Commentary: Does Infection With Specific Clostridium difficile Strains or Clades Influence Clinical Outcome?
- (2013) D. N. Gerding et al. CLINICAL INFECTIOUS DISEASES
- Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection
- (2013) A. Sarah Walker et al. CLINICAL INFECTIOUS DISEASES
- European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection
- (2013) S.B. Debast et al. CLINICAL MICROBIOLOGY AND INFECTION
- Diagnosis of Clostridium difficile Infection: an Ongoing Conundrum for Clinicians and for Clinical Laboratories
- (2013) C.-A. D. Burnham et al. CLINICAL MICROBIOLOGY REVIEWS
- Clostridium difficile infection in children hospitalized due to diarrhea
- (2013) K. Dulęba et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Protection from Clostridium difficile Infection in CD4 T Cell- and Polymeric Immunoglobulin Receptor-Deficient Mice
- (2013) Pehga F. Johnston et al. INFECTION AND IMMUNITY
- Identification of a novel type 2 innate immunocyte with the ability to enhance IgE production
- (2013) Ayumi Fukuoka et al. INTERNATIONAL IMMUNOLOGY
- Functional Characterization of Clostridium difficile Spore Coat Proteins
- (2013) P. Permpoonpattana et al. JOURNAL OF BACTERIOLOGY
- Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection
- (2013) Rodrigo Quera et al. Journal of Crohns & Colitis
- Role of Interleukin 23 Signaling in Clostridium difficile Colitis
- (2013) Erica L. Buonomo et al. JOURNAL OF INFECTIOUS DISEASES
- Importance of Toxin A, Toxin B, and CDT in Virulence of an Epidemic Clostridium difficile Strain
- (2013) Sarah A. Kuehne et al. JOURNAL OF INFECTIOUS DISEASES
- A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile
- (2013) R. G. K. Donald et al. MICROBIOLOGY-SGM
- Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria
- (2013) Matthew R. Hepworth et al. NATURE
- TH2, allergy and group 2 innate lymphoid cells
- (2013) Paula Licona-Limón et al. NATURE IMMUNOLOGY
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating Antibody and Memory B-Cell Responses to C. difficile Toxins A and B in Patients with C. difficile-Associated Diarrhoea, Inflammatory Bowel Disease and Cystic Fibrosis
- (2013) Tanya M. Monaghan et al. PLoS One
- Clostridium difficile toxin B-induced necrosis is mediated by the host epithelial cell NADPH oxidase complex
- (2013) M. A. Farrow et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of Clostridium difficile Toxin A and B on Human T Lymphocyte Migration
- (2013) Dan Wu et al. Toxins
- Difference in F-Actin Depolymerization Induced by Toxin B from the Clostridium difficile Strain VPI 10463 and Toxin B from the Variant Clostridium difficile Serotype F Strain 1470
- (2013) Martin May et al. Toxins
- Relapse Versus Reinfection: Recurrent Clostridium difficile Infection Following Treatment With Fidaxomicin or Vancomycin
- (2012) I. Figueroa et al. CLINICAL INFECTIOUS DISEASES
- Current Status of Clostridium difficile Infection Epidemiology
- (2012) F. C. Lessa et al. CLINICAL INFECTIOUS DISEASES
- Faecal microbiota transplantation for severe clostridium difficile infection in the intensive care unit
- (2012) Jason A. Trubiano et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Innate Lymphoid Cell Interactions with Microbiota: Implications for Intestinal Health and Disease
- (2012) Gregory F. Sonnenberg et al. IMMUNITY
- A Chimeric Toxin Vaccine Protects against Primary and Recurrent Clostridium difficile Infection
- (2012) Haiying Wang et al. INFECTION AND IMMUNITY
- Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection
- (2012) P.N. Wiegand et al. JOURNAL OF HOSPITAL INFECTION
- Clostridium difficile Spore-Macrophage Interactions: Spore Survival
- (2012) Daniel Paredes-Sabja et al. PLoS One
- Follicular Helper CD4 T Cells (TFH)
- (2011) Shane Crotty Annual Review of Immunology
- Host S-nitrosylation inhibits clostridial small molecule–activated glucosylating toxins
- (2011) Tor C Savidge et al. NATURE MEDICINE
- Host and Pathogen Factors forClostridium difficileInfection and Colonization
- (2011) Vivian G. Loo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fidaxomicin versus Vancomycin forClostridium difficileInfection
- (2011) Thomas J. Louie et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Changing Epidemiology of Clostridium difficile Infections
- (2010) J. Freeman et al. CLINICAL MICROBIOLOGY REVIEWS
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
- (2010) Daniel R. Neill et al. NATURE
- The role of toxin A and toxin B in Clostridium difficile infection
- (2010) Sarah A. Kuehne et al. NATURE
- Treatment with Monoclonal Antibodies againstClostridium difficileToxins
- (2010) Israel Lowy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon
- (2010) M. C. Rea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulatory T Cells Reinforce Intestinal Homeostasis
- (2009) Michael J. Barnes et al. IMMUNITY
- Toxin B is essential for virulence of Clostridium difficile
- (2009) Dena Lyras et al. NATURE
- Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
- (2009) Kazuyo Moro et al. NATURE
- Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)
- (2009) Brett A. Leav et al. VACCINE
- Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection
- (2008) S. Dial et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Clostridium difficile cell-surface polysaccharides composed of pentaglycosyl and hexaglycosyl phosphate repeating units
- (2008) Jeyabarathy Ganeshapillai et al. CARBOHYDRATE RESEARCH
- Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences
- (2008) R. A. Stabler et al. JOURNAL OF MEDICAL MICROBIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started